Eagle Meds Services
TEPEZZA (teprotumumab)
Available to sourceHuman Prescription DrugDiabetes & Endocrine

TEPEZZA (teprotumumab)

500 mg/1 · Lyophilized Injection Powder
By Horizon Therapeutics USA, Inc.
NDC
75987-130
Route
Intravenous
Therapeutic class
Insulin-like Growth Factor-1 Receptor Inhibitor , Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]
Marketing category
BLA

Package sizes

  • 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSENDC 75987-130-15Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
TEPEZZA (teprotumumab)
NDC 75987-130